Experimental Compound FRAX486 Reverses Signs of Fragile X in Mice

Experimental Compound FRAX486 Reverses Signs of Fragile X in Mice

With an $81,000 grant from FRAXA Research Foundation from 2005-2006, Dr. Susumu Tonegawa and his team at MIT studied the enzyme PAK to determine how it could be used for a treatment target. Results published.

Read more